Table 2.
Adverse event profile of participants after loading dose of HCQ (n=258)
| Adverse event | No. of participants (n=258) |
|---|---|
| Gastrointestinal (36)* | |
| Nausea | 23 (8.9%) |
| Diarrhoea | 9 (3.48%) |
| Gastritis | 9 (3.4%) |
| Other gastrointestinal | 5 (1.9) |
| Neurological (47)* | |
| Headache | 30 (12.1%) |
| Dizziness | 21 (8.5%) |
| Irritability | 9 (3.6%) |
| Other neurological | 5 (2%) |
| Palpitation | 5 (2%) |
| Allergic reaction | |
| Rash and itching | 3 (1.2%) |
| Swelling of lip and face | 1 (0.4%) |
| Others | 4 (1.6%) |
Number of participants reported more than one adverse event, so numbers do not add-up. *Composite side effects (gastrointestinal side effect: 36, neurological side effect: 47, both gastrointestinal and neurological side effect: 15)